SL12 murine T-lymphoma: a new model for tumor cell heterogeneity.
It has been observed that subclones from the spontaneous murine AKR/J T-lymphoma cell line SL12 with similar in vitro growth characteristics exhibit stable differences in tumorigenicity. The cell line is composed of at least three distinct cloned cell types that are highly, moderately, or poorly tumorigenic in syngeneic host animals. When healthy, young, syngeneic host animals were given iv injections with the same number of viable growth phase cells, each cloned cell type had a different tumor incidence, latent period, and pattern of tumor spread. The unusual stability of the cloned cell lines is shown by a similar incidence, latency, and spread of the tumors when studied after more than 1 year of continuous in vitro culture. The SL12 clones also differ in several phenotypic characteristics commonly used to classify thymocyte maturation, e.g., a) the expression of three of seven surface antigens examined, b) the cellular response to glucocorticoid hormone, and c) the expression of terminal deoxynucleotidyl transferase.
D000818:Animals; D000954:Antigens, Surface / Q000032:analysis; D002455:Cell Division / Q000187:drug effects; D002999:Clone Cells; D004247:DNA / Q000032:analysis; D004253:DNA Nucleotidylexotransferase / Q000032:analysis; D003907:Dexamethasone / Q000494:pharmacology; D008223:Lymphoma / Q000473:pathology* / Q000556:secondary / Q000648:ultrastructure; D051379:Mice; D008806:Mice, Inbred AKR; D009368:Neoplasm Transplantation; D009360:Neoplastic Cells, Circulating; D010641:Phenotype; D013601:T-Lymphocytes / Q000145:classification / Q000648:ultrastructure; D013945:Thymoma / Q000473:pathology
D000954:Antigens, Surface; D003907:Dexamethasone; D004247:DNA; D004253:DNA Nucleotidylexotransferase